About Otsuka Pharmaceutical India Private Limited
Data last updated:
Otsuka Pharmaceutical India Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Otsuka Pharmaceutical Factory Inc. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2012PTC072692. Its GSTIN is 24AAFCC0602G1ZD (Gujarat). The company holds 28 GST registrations, of which 14 are active.
The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹23.46 Cr. It was formerly known as Claris Speciality Injectables Limited and Claris Otsuka Private Limited. It is led by directors including Parag Avinashbhai Swadia (Whole-Time Director) and Kenta Koichi Tanaka (Whole-Time Director).
Its last annual general meeting (AGM) was held on 24 March 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village – Vasana – Chacharwadi Tal – Sanand, Ahmedabad, Gujarat, India – 382213.
As per the financials filed for FY 2025, the company reported a revenue of ₹593.16 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹25.48 Cr (net margin 4.3%) and EBITDA of ₹69.53 Cr (EBITDA margin 11.7%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 12% over five years.
The company has about 966 employees on its provident fund (EPFO) records.
Court records list 23 cases involving the company, including 15 filed by the company and 8 filed against it; 8 cases are pending. The company has 8 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹1,314.87 Cr; the latest was in December 2024. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations) are compared by revenue, 3 smaller; the largest is Wanbury Limited with revenue of ₹603.01 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website otsukapharma.in.
Company details
Name history
Otsuka Pharmaceutical India has undergone 3 name changes throughout its history. The company was previously known as Claris Speciality Injectables Limited, Claris Otsuka Private Limited, and Claris Otsuka Limited. The current legal name is Otsuka Pharmaceutical India Private Limited.
| Company Name | Status |
|---|---|
| Otsuka Pharmaceutical India Private Limited | Current |
| Claris Speciality Injectables Limited | Previous |
| Claris Otsuka Private Limited | Previous |
| Claris Otsuka Limited | Previous |
CIN history
Otsuka Pharmaceutical India has one previous CIN (Corporate Identification Number): U24230GJ2012PLC072692. The current CIN is U24230GJ2012PTC072692, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230GJ2012PTC072692 | Current |
| U24230GJ2012PLC072692 | Previous |
Contact details
Otsuka Pharmaceutical India Private Limited's registered office is in Ahmedabad, Gujarat. Its website is otsukapharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressVillage – Vasana – Chacharwadi Tal – Sanand, Ahmedabad, Gujarat, India – 382213
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Otsuka Pharmaceutical India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Otsuka Pharmaceutical India is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Otsuka Pharmaceutical India Private Limited, buy the company report.
Financials of Otsuka Pharmaceutical India Private Limited
FY 2025 filings availableOtsuka Pharmaceutical India Private Limited reported revenue of ₹593.16 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹593.16 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹69.53 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25.48 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.7% | ||||
| Net Profit Margin | 4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Otsuka Pharmaceutical India Private Limited, buy the company report.
Board of directors of Otsuka Pharmaceutical India Private Limited
Otsuka Pharmaceutical India has 5 current directors and 25 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parag Avinashbhai Swadia Also directs: Otsuka Nutraceutical India Private Limited | Whole-Time Director | 18 Dec 2018 | 7 Years 10 Months | Current |
| Tatsuaki Yoshikage Okada | Director | 28 Apr 2022 | 4 Years 6 Months | Current |
| Hidenari Hidekatsu Shoji | Director | 22 Jan 2025 | 1 Years 9 Months | Current |
| Kenta Koichi Tanaka | Whole-Time Director | 19 Jul 2024 | 2 Years 3 Months | Current |
| Kishore Bhupendra Upadhyay | Whole-Time Director | 24 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Otsuka Pharmaceutical India Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wanbury Limited | ₹603.01 Cr (FY 2025) | 4.0% | Navi Mumbai, Maharashtra, India | |||
| Malik Lifesciences Private Limited | ₹595.52 Cr (FY 2025) | 11.0% | Delhi, India | |||
| Otsuka Pharmaceutical India Private Limitedthis company | ₹593.16 Cr (FY 2025) | ₹25.48 Cr | 4.3% | -2.0% | 966 | Ahmedabad, Gujarat, India |
| Acme Formulation Private Limited | ₹577 Cr (FY 2025) | -2.0% | Himachal Pradesh, India |
To see the full peer comparison of Otsuka Pharmaceutical India Private Limited, buy the company report.
Auditor
Otsuka Pharmaceutical India Private Limited is audited by BSR and CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BSR and CO | FY 2024 | 128510W |
Shareholding
The shareholding of Otsuka Pharmaceutical India Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Otsuka Pharmaceutical India Private Limited, buy the company report.
Deals & funding
Otsuka Pharmaceutical India Private Limited has 8 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹1,314.87 Cr; the latest was in December 2024.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2024 | Rights issue | ₹565.8 Cr | Investors: Otsuka Pharmaceutical Factory Inc |
| Dec 2023 | Funding round | ₹264.47 Cr | Investors: Otsuka Pharmaceutical Factory Inc |
| Sep 2017 | Secondary share transfer | Undisclosed | Buyer: Otsuka Pharmaceutical Factory Inc Seller: Claris Lifesciences Limited , an individual |
| Jul 2013 | Secondary share transfer | Undisclosed | Buyer: Claris Lifesciences Limited Seller: 4 individuals |
| Jul 2013 | Acquisition | ₹1.95 Cr | Buyer: Claris Lifesciences Limited |
To see the full deal history of Otsuka Pharmaceutical India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Otsuka Pharmaceutical India Private Limited has 23 court cases on record: 15 filed by Otsuka Pharmaceutical India, 8 filed against it. 8 cases are pending and 15 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 14 | 7 | 7 |
| High courts | 8 | 1 | 1 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, KOPPAL, Karnataka | Criminal miscellaneous application | Filed by the company against Government of Karnataka Represented by Assistant Drugs Controller Koppal Circle | Pending |
| NCLT, Bengaluru | Insolvency matter | Filed by the company against Karnataka State Medical Suppliescorporation Limited | Disposed |
| District court, Ahmedabad, Gujarat | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| High Court of Gujarat | Special civil application | Filed against the company by an individual | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Union of India Represented by Arun Kumar Prashar, Drug Inspector | Pending |
To see the full case history of Otsuka Pharmaceutical India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Otsuka Pharmaceutical India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Otsuka Pharmaceutical India Private Limited has a workforce of 966 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 966 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Otsuka Pharmaceutical India Private Limited, buy the company report.
GST
Otsuka Pharmaceutical India has 28 GST registrations: 14 active and 14 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCC0602G1ZD | Gujarat | Active | 01 Jul 2017 |
| 24AAFCC0602G3ZB | Gujarat | Active | 19 Mar 2025 |
| 03AAFCC0602G2ZG | Punjab | Active | 01 Jul 2017 |
| 06AAFCC0602G1ZB | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Otsuka Pharmaceutical India Private Limited, buy the company report.
Recent activity
Otsuka Pharmaceutical India Private Limited has 29 board changes on record since 2013: 6 appointments and 23 cessations. The latest: Kishore Bhupendra Upadhyay was appointed as Whole-Time Director on 24 Mar 2025.
20 earlier events are in the company report.
News
Frequently asked questions
Otsuka Pharmaceutical India is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 November 2012 (14+ years old) and is registered under CIN U24230GJ2012PTC072692.
Otsuka Pharmaceutical India has 5 current directors:
- Parag Avinashbhai Swadia - Whole-Time Director
- Kenta Koichi Tanaka - Whole-Time Director
- Kishore Bhupendra Upadhyay - Whole-Time Director
- Tatsuaki Yoshikage Okada - Director
- Hidenari Hidekatsu Shoji - Director
The latest financial statements of Otsuka Pharmaceutical India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 March 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Otsuka Pharmaceutical India is 24AAFCC0602G1ZD, registered in Gujarat. The company has 28 GST registrations in all, of which 14 are active and 14 are cancelled or inactive. Other active GSTINs include 24AAFCC0602G3ZB (Gujarat), 03AAFCC0602G2ZG (Punjab), 06AAFCC0602G1ZB (Haryana).
The CIN (Corporate Identification Number) of Otsuka Pharmaceutical India is U24230GJ2012PTC072692. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Otsuka Pharmaceutical India has 23 court cases on record: 15 filed by the company and 8 filed against it. 8 are pending. Most are in the district courts.
Otsuka Pharmaceutical India was incorporated on 12 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Otsuka Pharmaceutical India has 8 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹1,314.87 Cr; the latest was in December 2024.
The peers of Otsuka Pharmaceutical India by revenue are Wanbury Limited, Malik Lifesciences Private Limited, Acme Formulation Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Kishore Bhupendra Upadhyay was appointed as Whole-Time Director on 24 Mar 2025. Kishore Bhupendra Upadhyay ceased to be Additional Director on 24 Mar 2025. Hidenari Hidekatsu Shoji ceased to be Additional Director on 23 Mar 2025. Otsuka Pharmaceutical India has 29 board changes on record in total.
Otsuka Pharmaceutical India can be reached through the website otsukapharma.in. Its registered office is in Ahmedabad, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
